2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow Keloids: new trials by email Literature Review of Keloids trials Research Report on Keloids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Metformin Versus Triamcinolone for Keloid Treatment Intralesional Metformin, Intralesional Triamcinolone Acetonide - Keloids | Phase 2 | Completed | Al-Azhar University | 30 | 2023-05-06 | 2026-11-06 |
| Sorafenib for Patients With Extensive Keloids Sorafenib - Keloids | Phase 2 | Terminated | Tirgan, Michael H., M.D. | 60 | 2013-03-01 | 2016-10-18 |
| Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence QAX576, QAX576 placebo - Keloids | Phase 2 | Terminated | Novartis Pharmaceuticals | 3 | 2009-06-01 | 2020-12-19 |
Keloid (3) · Recurrence (1)
Cicatrix (3) · Collagen Diseases (3) · Connective Tissue Diseases (3) · Fibrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Skin and Connective Tissue Diseases (3) · Disease Attributes (1)
Sorafenib (1)
Al-Azhar University (1) · Novartis Pharmaceuticals (1) · Tirgan, Michael H., M.D. (1)
United States (2) · Egypt (1)
Ghada O Abdel Aziz, MD (1) · Michael H Tirgan, MD (1)